Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Saori, Oka"'
Autor:
Miyuki Kimura, Risa Matsuoka, Satoshi Taniguchi, Junki Maruyama, Slobodan Paessler, Saori Oka, Atsushi Yamashita, Takasuke Fukuhara, Yoshiharu Matsuura, Hideki Tani
Lujo virus (LUJV), which belongs to Mammarenavirus, familyarenaviridae, has emerged as pathogen causing severe hemorrhage fever with high mortality. Currently, there are no effective treatments for arenaviruses, including LUJV. Here, we screened chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::883eecbe34ccb15f1029b2dcbab96b8a
https://doi.org/10.1101/2023.05.24.542186
https://doi.org/10.1101/2023.05.24.542186
Autor:
Takashi Tanikawa, Saori Oka, Keisuke Nakajima, Yasuhiro Hayashi, Yoko Nemoto-Sasaki, Yoichiro Arata, Takayuki Sugiura, Atsushi Yamashita
Publikováno v:
BPB Reports. 5:16-20
Autor:
Atsushi, Yamashita, Naoki, Matsumoto, Yoko, Nemoto-Sasaki, Saori, Oka, Seisuke, Arai, Ikuo, Wada
Publikováno v:
Methods in enzymology. 675
Protein phosphorylation is the most common post-translational modification of proteins and functions as a molecular switch for their regulation. This modification is reversibly regulated by protein kinases and phosphatases. In most cases, the phospho
Autor:
Atsushi Yamashita, Yasuhiro Hayashi, Naoki Matsumoto, Yoko Nemoto-Sasaki, Saori Oka, Takashi Tanikawa, Takayuki Sugiura
Publikováno v:
Biology, Vol 3, Iss 4, Pp 801-830 (2014)
Acyl-CoA:glycerol-3-phosphate acyltransferase (GPAT) and acyl-CoA: 1-acyl-glycerol-3-phosphate acyltransferase (AGPAT) are involved in the de novo synthesis of triacylglycerol (TAG) and glycerophospholipids. Many enzymes belonging to the GPAT/AGPAT f
Externí odkaz:
https://doaj.org/article/0318de84059841a9a10d04647a8ffe84
Autor:
Toru Tanaka, Takashi Tanikawa, Yoichiro Arata, Norihiko Fujii, Tomoharu Takeuchi, Mayumi Tamura, Tomomi Hatanaka, Seishi Kishimoto, Saori Oka
Publikováno v:
Biological and Pharmaceutical Bulletin. 43:356-360
Galectins are a group of animal lectins characterized by their specificity for β-galactosides. Of these, galectin-2 (Gal-2) is predominantly expressed in the gastrointestinal tract. In the current study, we used a mouse gastric mucous fraction to in
Publikováno v:
Integrated Methods in Protein Biochemistry: Part A ISBN: 9780323992664
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cbbe99e2f092b6b1e4cc41b000c9750
https://doi.org/10.1016/bs.mie.2022.07.011
https://doi.org/10.1016/bs.mie.2022.07.011
Publikováno v:
Journal of Pharmacological Sciences, Vol 96, Iss 4, Pp 367-375 (2004)
2-Arachidonoylglycerol is an endogenous ligand for the cannabinoid receptors. To date, two types of cannabinoid receptors (CB1 and CB2) have been identified. The CB1 receptor is assumed to be involved in the attenuation of synaptic transmission. On t
Externí odkaz:
https://doaj.org/article/60f9f1cc890f4e5b9889a8e5ce9fb656
Autor:
Keisuke Nakajima, Saori Oka, Takashi Tanikawa, Yoko Nemoto-Sasaki, Naoki Matsumoto, Hiroki Ishiguro, Yoichiro Arata, Takayuki Sugiura, Atsushi Yamashita
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 18; Pages: 10932
We previously reported that lysophosphatidylinositol (LPI) functions as an endogenous agonist of GPR55, a novel cannabinoid receptor. However, the physiological roles of LPI-GPR55 have not yet been elucidated in detail. In the present study, we found
Autor:
Saori Oka, A. Iwakoshi, Akane Ishida, Atsushi Torii, Arisa Yamada, Yoshihito Kogure, Masashi Nakahata, Masahide Oki, H. Niwa, Hideo Saka, Fumie Shigematsu, Chiyoe Kitagawa
Publikováno v:
A70. ADVANCES IN LUNG CANCER THERAPEUTICS.
Autor:
Hiroshige Yoshioka, Akihiro Nishiyama, Naoki Watanabe, Hideo Saka, Kazuya Tsubouchi, Chiyoe Kitagawa, Masahiko Ando, Yoshihito Kogure, Saori Oka, Masahiro Iwasaku, Kei Kunimasa
Publikováno v:
In Vivo. 33:163-166
Background Amrubicin hydrochloride is administered as second- or third-line therapy for small cell lung cancer, and is known to cause severe myelotoxicity. This study evaluated the efficacy and safety of weekly amrubicin for refractory/relapsed small